Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oric Pharmaceuticals (ORIC)
NASDAQ:ORIC
RESEARCH TOOLSreports
Holding ORIC?
Track your performance easily
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| EBIT | $ -34.57M | $ -31.96M | $ -28.99M | $ -31.43M | $ -28.68M |
| EBITDA | $ -34.30M | $ -29.46M | $ -28.73M | $ -31.16M | $ -28.43M |
| Net Income Common Stockholders | $ -34.57M | $ -31.96M | $ -25.01M | $ -28.33M | $ -25.48M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 272.37M | $ 286.41M | $ 316.78M | $ 208.19M | $ 227.30M |
| Total Assets | $ 302.07M | $ 328.91M | $ 350.79M | $ 252.01M | $ 274.33M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -272.37M | $ -286.41M | $ -316.78M | $ -208.19M | $ -227.30M |
| Total Liabilities | $ 28.08M | $ 26.51M | $ 22.14M | $ 27.92M | $ 26.92M |
| Stockholders Equity | $ 273.99M | $ 302.40M | $ 328.68M | $ 224.09M | $ 247.41M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -29.21M | $ -25.96M | $ -30.40M | $ -24.33M | $ -19.72M |
| Operating Cash Flow | $ -28.80M | $ -25.63M | $ -30.19M | $ -24.27M | $ -19.64M |
| Investing Cash Flow | $ 23.07M | $ 18.28M | $ -61.87M | $ 20.96M | $ -57.83M |
| Financing Cash Flow | $ 126.00K | $ 816.00K | $ 125.03M | $ 453.00K | $ 31.00K |